UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recommendations for including multiple symptoms as endpoints in cancer clinical trials

Cancer, 2013-01, Vol.119 (2), p.411-420

2013

Volltextzugriff (PDF)

Nora Janjan, MD, MPSA, MBA: More Resources Than Ever, but Suicide Risk in Patients and Providers Hasn't Changed

Oncology (Williston Park, N.Y.), 2019-06, Vol.33 (6), p.221

Janjan, Nora

2019

Volltextzugriff (PDF)

External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations

Frontiers in medicine, 2023-07, Vol.10, p.1198088-1198088

2023

Volltextzugriff (PDF)

The Trauma of Facing Death

Oncology (Williston Park, N.Y.), 2018-03, Vol.32 (3), p.97

Janjan, Nora

2018

Volltextzugriff (PDF)

Palliative Radiation Oncology: Reflecting a Realistic Shift in the Priorities of Cancer Treatment

Journal of Pain and Symptom Management, 2013-10, Vol.46 (4), p.603-604

Janjan, Nora, MD, MPSA, MBA, FACP, FACR, FASTRO, FASCO

2013

Volltextzugriff (PDF)

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

American journal of clinical oncology, 2001-04, Vol.24 (2), p.107-112

2001

Volltextzugriff (PDF)

American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1378-1391

2000

Volltextzugriff (PDF)

Bone metastases: Approaches to management

Seminars in oncology, 2001-08, Vol.28 (4I), p.28-34, Article asonc02804i0028

Janjan, Nora

2001

Volltextzugriff (PDF)

EXPERT COMMENTARY

Contemporary ob/gyn, 2015-06, Vol.60 (6), p.27

Janjan, Nora

2015

Volltextzugriff (PDF)

Retrospective real-world comparison of clinical and economic burden between first-generation and second-generation tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19030-e19030

2021

Volltextzugriff (PDF)

Radiation Oncology

Oncology (Williston Park, N.Y.), 2011-04, Vol.25 (5), p.398

Janjan, Nora

2011

Volltextzugriff (PDF)

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer

Prostate cancer and prostatic diseases, 2022-09, Vol.25 (3), p.524-530

2022

Volltextzugriff (PDF)

Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?

Future oncology (London, England), 2023-10, Vol.19 (31), p.2075-2082

2023

Volltextzugriff (PDF)

Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Clinical genitourinary cancer, 2023-08, Vol.21 (4), p.419-429

2023

Volltextzugriff (PDF)

Overall survival (OS) in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving bicalutamide (BIC) followed by enzalutamide (ENZA) or abiraterone (ABI)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.40-40

2020

Volltextzugriff (PDF)

Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?

Future oncology (London, England), 2022-10, Vol.18 (34), p.3783-3790

2022

Volltextzugriff (PDF)

Health services utilization and payments in patients with cancer pain: A comparison of intrathecal drug delivery versus conventional medical management

Journal of clinical oncology, 2014-11, Vol.32 (31_suppl), p.125-125

2014

Volltextzugriff (PDF)

COVID‐19 associated disruptions in routine health care of people with mild cognitive impairment or dementia

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2022, Vol.14 (1), p.e12323-n/a

2022

Volltextzugriff (PDF)

Palliation and supportive care in radiation medicine: Radiation medicine update for the practicing oncologist, part I

Hematology/oncology clinics of North America, 2006, Vol.20 (1)

JANJAN, Nora

2006

Volltextzugriff (PDF)

Cisplatin‐based combined modality therapy for anal carcinoma

Cancer, 2003-03, Vol.97 (5), p.1195-1202

2003

Volltextzugriff (PDF)

An emerging respect for palliative care in radiation oncology

Journal of palliative medicine, 1998-03, Vol.1 (1), p.83-88

Janjan, N A

1998

Volltextzugriff (PDF)

Quality Improvement Guidelines for the Treatment of Acute Pain and Cancer Pain

JAMA : the journal of the American Medical Association, 1995-12, Vol.274 (23), p.1874

Max, Mitchell B.

1995

Volltextzugriff (PDF)

Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer

Gastrointestinal cancer research, 2007-03, Vol.1 (2), p.44-48

2007

Volltextzugriff (PDF)

Gastrointestinal Cancer

1. Aufl., 2005

Volltextzugriff (PDF)

Reply to J.R. Gralow et al

Journal of clinical oncology, 2011-09, Vol.29 (26), p.3592-3593

2011

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(86)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Oncology
(16)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Colorectal Cancer
(5)
Cancer
(4)
Gastric Cancer
(4)
Radiology
(4)
Rectal Cancer
(4)
Familial Adenomatous Polyposis
(3)
Hematology, Oncology And Palliative Medicine
(3)
Medicine
(3)
Radiat Oncol Biol Phys
(3)
Surgery
(3)
Survival
(3)
Advanced Prostate Cancer
(2)
Antineoplastic Agents
(2)
Cancer Research
(2)
Care And Treatment
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recommendations for including multiple symptoms as endpoints in cancer clinical trials

Nora Janjan, MD, MPSA, MBA: More Resources Than Ever, but Suicide Risk in Patients and Providers Hasn't Changed

External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations

The Trauma of Facing Death

Palliative Radiation Oncology: Reflecting a Realistic Shift in the Priorities of Cancer Treatment

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer

Bone metastases: Approaches to management

EXPERT COMMENTARY

Retrospective real-world comparison of clinical and economic burden between first-generation and second-generation tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML)

Radiation Oncology

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer

Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?

Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Overall survival (OS) in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving bicalutamide (BIC) followed by enzalutamide (ENZA) or abiraterone (ABI)

Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?

Health services utilization and payments in patients with cancer pain: A comparison of intrathecal drug delivery versus conventional medical management

COVID‐19 associated disruptions in routine health care of people with mild cognitive impairment or dementia

Palliation and supportive care in radiation medicine: Radiation medicine update for the practicing oncologist, part I

Cisplatin‐based combined modality therapy for anal carcinoma

An emerging respect for palliative care in radiation oncology

Quality Improvement Guidelines for the Treatment of Acute Pain and Cancer Pain

Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer

Gastrointestinal Cancer

Reply to J.R. Gralow et al

Aktive Filter

Suchergebnisse filtern